Medications & Supplements/Dietary Supplements

SUSTANGO Capsules Recalled for Undeclared Tadalafil

Agency Publication Date: August 1, 2022

Summary

Ultra Supplement LLC is recalling approximately 750 cartons of SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg. Testing revealed the product contains tadalafil, an undeclared drug ingredient typically found in prescription medications for erectile dysfunction. This 10-count supplement was sold nationwide through Amazon Marketplace.

Risk

Undeclared tadalafil can interact with nitrates found in some prescription drugs, which may lower blood pressure to dangerous or life-threatening levels. This is especially risky for people with heart disease, diabetes, high blood pressure, or high cholesterol who may already be taking nitrates.

What You Should Do

This recall affects 10-count blister cartons of SUSTANGO (Pendenadril Tytrate Blend) Capsules (400 mg) labeled with lot number DAP272109 and an expiration date of 4/1/2026. The product packaging also displays ASIN X0024468I9 and identifies the product as being formulated by Male FX Labs of Bangor, ME.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Ultra Supplement LLC for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: SUSTANGO (Pendenadril Tytrate Blend) Capsules (400 mg)

Variants: 400 mg, 10-count blisters

Lot Numbers:

DAP272109 (Exp: 4/1/2026)

ASIN X0024468I9. Formulated by: Male FX Labs, Bangor, ME.

Product Images

“Sustango, 400 mg (Pendenadril Tytrate Blend), 10 capsules”

“Supplement Facts, Formulated by: Male FX Labs, Bangor, ME”

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 90659

Status: Resolved

Manufacturer: Ultra Supplement LLC

Sold By: Amazon Marketplace; www.amazon.com

Manufactured In: United States

Units Affected: 750 cartons

Distributed To: Nationwide

Agency Last Updated: August 17, 2022

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects 10-count blister cartons of SUSTANGO (Pendenadril Tytrate Blend) Capsules (400 mg) labeled with lot number DAP272109 and an expiration date of 4/1/2026. The product packaging also displays ASIN X0024468I9 and identifies the product as being formulated by Male FX Labs of Bangor, ME.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Ultra Supplement LLC for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.